Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision
Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a filing showed on Thursday, ahead of an expected decision by the U.S. Food and Drug Administration in April.
More info
